Are Divi's Lab. latest results good or bad?
Divis Laboratories reported strong financial results for the quarter ending March 2025, with net sales of Rs 2,585 crore and a profit after tax of Rs 662 crore, both marking significant growth. Overall, the company's performance indicates a positive financial trajectory and solid operational efficiency.
Divis Laboratories has reported its financial results for the quarter ending March 2025, showcasing a notable performance across several key metrics. The company achieved net sales of Rs 2,585.00 crore, which represents the highest quarterly sales in the last five quarters, reflecting strong operational capabilities. The operating profit reached Rs 885.00 crore, with an operating profit margin of 34.24%, indicating enhanced efficiency in operations. Additionally, the profit before tax (PBT) was recorded at Rs 778.00 crore, demonstrating a growth of 28.6% compared to the average of the previous four quarters. The profit after tax (PAT) also showed robust performance, hitting Rs 662.00 crore, up by 28.1% from the prior average, further emphasizing the company's solid financial health.
Earnings per share (EPS) reached Rs 24.98, marking the highest level in the last five quarters, which reflects the company's commitment to enhancing shareholder value.
Overall, Divis Laboratories continues to exhibit a positive financial trajectory, reinforcing its position within the pharmaceuticals and biotechnology industry. It is also noted that the company saw an adjustment in its evaluation during this reporting period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
